Plexus shares are pushing higher as the market continues to price in a stronger start to fiscal 2026 and a constructive near-term outlook. Recent catalyst coverage points to investors leaning into the company’s momentum and optimistic positioning after its fiscal Q1 update, keeping incremental demand in the stock even without a same-day headline. (tipranks.com)

In its fiscal first quarter 2026 update (released January 28, 2026), Plexus reported revenue of $1.070 billion and non-GAAP EPS of $1.78, alongside commentary that growth was supported by strength in Healthcare/Life Sciences and Aerospace/Defense. The company also issued fiscal Q2 2026 guidance of $1.11–$1.15 billion in revenue and non-GAAP EPS of $1.80–$1.95, which has helped reinforce the view that demand and execution are holding up in its more resilient end markets. (globenewswire.com)

With the next fiscal Q2 2026 earnings window approaching later in April 2026, the stock can remain sensitive to positioning and expectation-setting around whether Plexus can deliver on the guided step-up and maintain margin discipline. Market calendars point to an expected Q2 earnings timing around April 22, 2026, putting the name back on near-term watchlists as investors anticipate another read on demand trends. (marketbeat.com)